Erasca: 'Hold' On Substantial RAS Targeting ERAS-0015 But With Two Key Risks

🇺🇸 Seeking Alpha (US) —

AI Summary

Erasca is facing pressures regarding its RAS targeting ERAS-0015 due to two significant risks that could impact its future performance. Investors are advised to take a cautious approach amid these developments.

Markets Deals Health Erasca health investment risks pharmaceuticals

Read original source →